Cannabis Law Report

AUGUST 17, 2021

We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. percent, consistent with the Marigold Phase 3 CDKL5 deficiency disorder trial of 24.5 Chief Medical Officer of Marinus. “We Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. 124’—the use and application of medicines manufactured from “marijuana” to any person are currently prohibited.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Cannabis Law Report

DECEMBER 18, 2019

. …MGC Pharmaceuticals has achieved yet another significant milestone with the bio-pharma company this week surpassing more than 1,800 prescribed products of its medicinal cannabis-based pharmaceutical products in Australia, UK, Brazil and Ireland.

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

AUGUST 21, 2019

The National Institute for Health and Care Excellence (NICE) reviewed evidence for the benefits and costs of cannabis-based medicinal products and drew up guidance for health professionals and the public. It also said the children’s experiences on medicinal cannabis in the should be taken into account as evidence of how well the drug works.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

CannaTech

SEPTEMBER 16, 2018

While Canada’s medicinal cannabis framework has gone through many iterations, Canada has led the way in showing to the world how to think about cannabis. What began as a legal medicine more than 15 years is now being legalized for adult recreational use. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Info

OCTOBER 11, 2019

Epidiolex is an epilepsy-fighting cannabis base drug produced by GW Prescription drugs. In Europe, there are round 50,000 young adults and children affected by one of many two signs of epilepsy. This approval is the fruits of a few years of dedication and collaboration between GW, physicians and the epilepsy neighborhood.

Business 45

Business Epilepsy Clinical Trials Treatment 45

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Many people prefer to consume cannabis, both recreationally and medicinally, by smoking.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

APRIL 10, 2019

He added, “I welcome the trials and I welcome the review, but, sadly, people need these medicines now. My sympathies go out to the patients and their families who are desperately seeking to alleviate their symptoms with medicinal cannabis. Can we unlock the door?”. We are working hard to get the right approach.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Veriheal

AUGUST 31, 2020

These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.

Research and Development 117

Research and Development Education Agriculture Patients 117

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. Acceptance of Medicinal Cannabis. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Canna Care Docs

DECEMBER 16, 2020

Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. What conditions is medical marijuana helpful for?

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. As more physicians and healthcare professionals advocate for the integration of medical marijuana into treatment plans, public trust in its medicinal value has grown.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JULY 15, 2019

Law 33/2018 set the framework for the regulation of the use of cannabis-based medicinal products, preparations and substances that would effectively allow Portuguese patients to access medical cannabis What really has changed during the last year? July 18 marks the first anniversary of the Portuguese medical cannabis law.

Medicine 40

Medicine Clinical Trials Patients Access 40

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. Acceptance of Medicinal Cannabis. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Greencamp

AUGUST 16, 2018

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 26, 2019

Devices that are used to administer medicines, for example a transdermal patch containing medicine, are regulated as a medicine rather than a medical device. The TGA provides guidance on the appropriate classification of products that are on the device-medicine boundary. One such circumstance is a clinical trial.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JANUARY 26, 2022

The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. No drug is without risks, so clinical trials have included careful investigation of possible adverse effects.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

MGC Pharma

FEBRUARY 20, 2018

CBD passes Stage 3 clinical trial for the treatment of epilepsy in children A study published last year in The New England Journal of Medicine saw scientists studying the effects of CBD on epileptic seizures in patients with Dravet syndrome, a severe epileptic disorder leading to frequent and uncontrollable seizures in children.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Peninsula Alternative Health

MAY 15, 2019

The challenging part is that every individual strain is a different medicine and every individual cancer is a different disease. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Naturally, cells in our bodies are not mobile but cancer cells are.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. How controversial were the changes in the law?

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Peninsula Alternative Health

MAY 15, 2019

The challenging part is that every individual strain is a different medicine and every individual cancer is a different disease. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Naturally, cells in our bodies are not mobile but cancer cells are.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

The Cannigma

MAY 7, 2021

The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. You’ve had this conversation in the US for over 20 years in some states so it’s not as if suddenly overnight, people have woken up to the discussion of cannabis and cannabis legalization and cannabis access. Music by Desca.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

JULY 15, 2022

The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. “It’s very important from our perspective to ensure that the Australian patient gets medicine first. The ABC reported back in 2018.

Medicine 52

Medicine Patients Media Supply Chain 52

SMPL

MAY 26, 2020

That’s because the federal government’s insistence that cannabis has no legitimate use as a medicine created two enormous problems: the proliferation of fake CBD products and the nonsensical separation of CBD from THC. Alas, Mr. Gardner wrote in 2005, that would require access to expensive testing equipment.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

DECEMBER 22, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. We’ve got our regular segment with Americans for Safe Access. We have autism and epilepsy. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Medicinal Marijuana Association

AUGUST 27, 2019

Back then, accessing cannabis for research purposes was not necessarily simple. More clinical trials in cannabis are currently being conducted in this tiny countrythan in any other country across the globe. The post Raphael Mechoulam: Pioneer Cannabis Researcher appeared first on Medicinal Marijuana Association.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Cannabis Law Report

AUGUST 12, 2019

It is cultivated mainly for medicinal and “recreational” purposes. states have instituted legislation to regulate its cultivation and allow its use as medicine. The amendment reverses a VA directive that prevents VA physicians from helping veterans access medical cannabis. However, many U.S. This would include CBD oil.

CBD 40

CBD Terpenes Oil Tincture 40